Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability
Raloxifene (RLX) is a second-generation selective estrogen receptor modulator used to treat osteoporosis in postmenopausal women. RLX fails to be developed into injectable dosage forms due to poor solubility. Although oral formulations are clinically available, the lower bioavailability (<2%) embarr...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis Group
2021-01-01
|
| Collection: | Drug Delivery |
| Sujets: | |
| Accès en ligne: | http://dx.doi.org/10.1080/10717544.2021.1872742 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|